Phase I trial combining motexafin gadolinium with docetaxel in the treatment of advanced solid tumors.

被引：0
|
作者：
Phan, S
Messina, P
Buffan, M
Salemi, ML
Pandya, K
Wilmot, JP
机构：
[1] Pharmacycl Inc, Sunnyvale, CA USA
[2] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3203
引用
收藏
页码：244S / 244S
页数：1
相关论文
共 50 条
  • [1] A phase 1 trial of motexafin gadolinium and docetaxel for advanced solid tumors.
    Ramnath, N
    Chatta, G
    Egorin, M
    Phan, S
    Creaven, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 237S - 237S
  • [2] A phase I trial of motexafin gadolinium with docetaxel in advanced solid tumors
    Pandya, Kishan J.
    Phan, See-Chun
    ANNALS OF ONCOLOGY, 2004, 15 : 107 - 108
  • [3] Phase I trial of motexafin gadolinium (MGd) and docetaxel (D) chemotherapy in the treatment of advanced solid tumors
    Petro, DP
    Egorin, MJ
    Ramanathan, RK
    Ramalingham, S
    Friedland, D
    Phan, SC
    Brown, L
    Naret, CL
    Belani, CP
    Chatta, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 232S - 232S
  • [4] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [5] Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
    Traynor, Anne M.
    Thomas, James P.
    Ramanathan, Ramesh K.
    Mody, Tarak D.
    Alberti, Dona
    Wilding, George
    Bailey, Howard H.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) : 316 - 322
  • [6] Phase I study of weekly docetaxel and topotecan in the treatment of advanced solid tumors.
    Tan, BR
    Read, W
    Bergeron, K
    Fracasso, PM
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 702S - 702S
  • [7] Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
    Anne M. Traynor
    James P. Thomas
    Ramesh K. Ramanathan
    Tarak D. Mody
    Dona Alberti
    George Wilding
    Howard H. Bailey
    Investigational New Drugs, 2011, 29 : 316 - 322
  • [8] Combination motexafin gadolinium (MGd) and docetaxel is active in recurrent lung and other solid tumors: Results of a phase I trial
    Phan, SC
    Pandya, KJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 226S - 226S
  • [9] Phase I trial of weekly irinotecan plus docetaxel in patients with advanced solid tumors.
    Font, A
    Sánchez, JM
    Guillot, M
    Abad, A
    Taron, M
    Margelí, M
    Barnadas, A
    Rosell, R
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
  • [10] A phase I study of lenalidomide and weekly docetaxel in patients with advanced solid tumors.
    Papadopoulos, K
    Mendelson, D
    Preston, GG
    Lopez, AM
    Ricart, AD
    Schwartz, G
    Needle, MN
    Gordon, MS
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9116S - 9116S
12345